351 – 360 of 1063
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Fetma är inte självklart skadlig hos alla individer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Microbiota patterns and risk of cardiometabolic disease - Opportunities for intervention?
(
- Contribution to journal › Article
-
Mark
DPP-4 inhibition and blood pressure lowering in perspective.
(
- Contribution to journal › Article
-
Mark
Kan en samlingsfaktura innehålla olika typer av transaktioner?
2016) In Balans Fördjupning(
- Contribution to journal › Article
-
Mark
Liraglutid minskade mortalitet i högriskgrupp av typ 2-diabetiker
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Metabolomic signatures in atherosclerotic disease : What is the potential use?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Antihypertensive treatment in critical limb Ischaemia
(
- Contribution to journal › Scientific review
-
Mark
Ny evidens för nyttan av primärpreventiv lipidsänkning
(
- Contribution to journal › Article
-
Mark
Introduction to a special issue : Hypertension in type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Combining the parabolic synthesis methodology with second-degree interpolation
(
- Contribution to journal › Article